Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Peter McCullough and Kristen Tecson.
Peter McCullough
Connection Strength
7.229
Kristen Tecson
  1. Major Adverse Renal and Cardiac Events After Coronary Angiography and Cardiac Surgery. Ann Thorac Surg. 2018 06; 105(6):1724-1730.
    View in: PubMed
    Score: 0.753
  2. Optimal cut points of plasma and urine neutrophil gelatinase-associated lipocalin for the prediction of acute kidney injury among critically ill adults: retrospective determination and clinical validation of a prospective multicentre study. BMJ Open. 2017 Jul 10; 7(7):e016028.
    View in: PubMed
    Score: 0.724
  3. Interpretation of positive troponin results among patients with and without myocardial infarction. Proc (Bayl Univ Med Cent). 2017 Jan; 30(1):11-15.
    View in: PubMed
    Score: 0.698
  4. Relation between proprotein convertase subtilisin/kexin type 9 and directly measured low-density lipoprotein cholesterol. Proc (Bayl Univ Med Cent). 2017 Jan; 30(1):16-20.
    View in: PubMed
    Score: 0.698
  5. Impact of renin-angiotensin-aldosterone system inhibitor continuation on outcomes for patients with severe coronavirus disease 2019 manifestations. J Hypertens. 2021 08 01; 39(8):1725-1726.
    View in: PubMed
    Score: 0.240
  6. Six-Month Outcomes for COVID-19 Negative Patients with Acute Myocardial Infarction Before Versus During the COVID-19 Pandemic. Am J Cardiol. 2021 05 15; 147:16-22.
    View in: PubMed
    Score: 0.233
  7. Role of endothelial cell receptors in the context of SARS-CoV-2 infection (COVID-19). Proc (Bayl Univ Med Cent). 2021 Jan 26; 34(2):262-268.
    View in: PubMed
    Score: 0.232
  8. Screening, detection, and management of heart failure in the SARS-CoV2 (COVID-19) pandemic. Heart Fail Rev. 2021 07; 26(4):973-979.
    View in: PubMed
    Score: 0.231
  9. Delays in Presentation in Patients With Acute Myocardial Infarction During the COVID-19 Pandemic. Cardiol Res. 2020 Dec; 11(6):386-391.
    View in: PubMed
    Score: 0.228
  10. Antecedent Administration of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Antagonists and Survival After Hospitalization for COVID-19 Syndrome. J Am Heart Assoc. 2020 11 17; 9(22):e017364.
    View in: PubMed
    Score: 0.227
  11. Endothelial dysfunction contributes to COVID-19-associated vascular inflammation and coagulopathy. Rev Cardiovasc Med. 2020 09 30; 21(3):315-319.
    View in: PubMed
    Score: 0.226
  12. Vitamin D deficiency in association with endothelial dysfunction: Implications for patients with COVID-19. Rev Cardiovasc Med. 2020 09 30; 21(3):339-344.
    View in: PubMed
    Score: 0.226
  13. Inpatient Mortality According to Level of Respiratory Support Received for Severe Acute Respiratory Syndrome Coronavirus 2 (Coronavirus Disease 2019) Infection: A Prospective Multicenter Study. Crit Care Explor. 2020 Sep; 2(9):e0220.
    View in: PubMed
    Score: 0.226
  14. Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection. Am J Med. 2021 01; 134(1):16-22.
    View in: PubMed
    Score: 0.224
  15. Characteristics and Outcomes in Patients Presenting With COVID-19 and ST-Segment Elevation Myocardial Infarction. Am J Cardiol. 2020 09 15; 131:1-6.
    View in: PubMed
    Score: 0.223
  16. Impact of Durable Ventricular Assist Device Support on Outcomes of Patients with Congenital Heart Disease Waiting for Heart Transplant. ASAIO J. 2020 05; 66(5):513-519.
    View in: PubMed
    Score: 0.220
  17. Alteration of lipid metabolism in chronic kidney disease, the role of novel antihyperlipidemic agents, and future directions. Rev Cardiovasc Med. 2018 Sep 30; 19(3):77-88.
    View in: PubMed
    Score: 0.197
  18. Cardiorenal Outcomes in the CANVAS, DECLARE-TIMI 58, and EMPA-REG OUTCOME Trials: A Systematic Review. Rev Cardiovasc Med. 2018 Jun 30; 19(2):41-49.
    View in: PubMed
    Score: 0.194
  19. Inhibition of the Sodium-Proton Antiporter (Exchanger) is a Plausible Mechanism of Potential Benefit and Harm for Drugs Designed to Block Sodium Glucose Co-transporter 2. Rev Cardiovasc Med. 2018 Jun 30; 19(2):51-63.
    View in: PubMed
    Score: 0.194
  20. Identifying suspected familial chylomicronemia syndrome. Proc (Bayl Univ Med Cent). 2018 Jul; 31(3):284-288.
    View in: PubMed
    Score: 0.192
  21. Usefulness of alirocumab and evolocumab for the treatment of patients with diabetic dyslipidemia. Proc (Bayl Univ Med Cent). 2018 Apr; 31(2):180-184.
    View in: PubMed
    Score: 0.191
  22. Prognostic value of urinary 11-dehydro-thromboxane B2 for mortality: A cohort study of stable coronary artery disease patients treated with aspirin. Catheter Cardiovasc Interv. 2018 10 01; 92(4):653-658.
    View in: PubMed
    Score: 0.186
  23. Residual thromboxane activity and oxidative stress: influence on mortality in patients with stable coronary artery disease. Coron Artery Dis. 2017 Jun; 28(4):287-293.
    View in: PubMed
    Score: 0.180
  24. Balancing Low-density Lipoprotein Cholesterol Reduction and Hepatotoxicity With Lomitapide Mesylate and Mipomersen in Patients With Homozygous Familial Hypercholesterolemia. Rev Cardiovasc Med. 2017; 18(1):21-28.
    View in: PubMed
    Score: 0.175
  25. Mortality Risk Assessment Using CHA(2)DS(2)-VASc Scores in Patients Hospitalized With Coronavirus Disease 2019 Infection. Am J Cardiol. 2020 12 15; 137:111-117.
    View in: PubMed
    Score: 0.057
  26. Ventricular Fibrillation Storm in Coronavirus 2019. Am J Cardiol. 2020 11 15; 135:177-180.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.